Results 211 to 220 of about 46,962 (257)

Progression significance for low-level aberrant B-lymphoblasts in chronic myeloid leukaemia patients. [PDF]

Clin Transl Med
Wang H, Wang H, Li Y, Zheng B, Fang Q, Li Y, Liu Y, Gu R, Wang Y, Mi Y, Liu B, Wei H, Wang J.   +12 more
europepmc   +1 more source

Comparing therapeutic effects of hematopoietic stem cell transplantation, tyrosine kinase inhibitors and chemotherapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: a systematic review and meta-analysis. [PDF]

Front Oncol
Gao X, Zeng H, Sun F, Zhao X, Wu H, Yan M, Li Y, Fu Q, Zhang G.   +8 more
europepmc   +1 more source

Submicron-oleogel particles for enhanced oral delivery of hydrophobic compounds: <i>In vitro</i> and <i>in vivo</i> proof of concept. [PDF]

Mater Today Bio
Ashkar A, Awad R, Lesmes U, Sosnik A, Davidovich-Pinhas M.   +4 more
europepmc   +1 more source

DE-ESCALATION OF TYROSINE KINASE INHIBITOR THERAPY IS SAFE IN CHRONIC MYELOID LEUKAEMIA IN DURABLE MOLECULAR RESPONSE (>= MR3 FOR >= 12 MONTHS): INITIAL RESULTS IN THE BRITISH DESTINY STUDY [PDF]

, 2016
Apperley, J, Clark, R, Coffey, T, Copland, M, Foroni, L, O'Brien, S, Pocock, C, Polydoros, F, Salim, R, Smith, G   +9 more
core  

HPLC–MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC)

, 2011
Antonio D’Avolio, Marco Simiele, Silvia De Francia, Alessandra Ariaudo, Lorena Baietto, Jessica Cusato, Carmen Fava, Giuseppe Saglio, Francesco Di Carlo, Giovanni Di Perri   +9 more
openalex   +2 more sources

Association of fibronectin 1 deregulation with tyrosine kinase inhibitor resistance in chronic myeloid leukemia. [PDF]

Front Cell Dev Biol
Tiedemann L, Gorantla SP, Ahlf P, Schmidt LS, Pott C, Litterst M, Waetzig V, Nagel I, Ruemenapp J, von Bubnoff N, Cascorbi I, Kaehler M.   +11 more
europepmc   +1 more source

Dasatinib and chemotherapy in a patient with early T‑cell precursor acute lymphoblastic leukemia and NUP214‑ABL1 fusion: A case report

, 2017
Yan Chen, Li Zhang, Jiankun Huang, Xiuli Hong, Jiangning Zhao, Zhao Wang, Kejie Zhang   +6 more
openalex   +2 more sources

US intergroup study of chemotherapy plus dasatinib and allogeneic stem cell transplant in Philadelphia chromosome positive ALL [PDF]

, 2016
Uy, Geoffrey L.
core   +1 more source

The Emerging Role of Senolysis in Atherosclerosis. [PDF]

Medicina (Kaunas)
Vagena S, Theocharous G, Theodorou A, Pantelis P, Gravanis M, Tscheuschner L, Theodorou A, Galyfos G, Sigala F, Lagopati N, Kotsinas A.   +10 more
europepmc   +1 more source

Efficacy of Molecular Response at 1 or 3 Months after the Initiation of Dasatinib Treatment Can Predict an Improved Response to Dasatinib in Imatinib-Resistant or Imatinib-Intolerant Japanese Patients with Chronic Myelogenous Leukemia during the Chronic Phase

, 2014
Koiti Inokuchi, Takashi Kumagai, Eri Matsuki, Kazuteru Ohashi, Atsushi Shinagawa, Yoshihiro Hatta, Jin Takeuchi, Chikashi Yoshida, Hisashi Wakita, Yasuji Kozai, Yukari Shirasugi, Shin Fujisawa, Osamu Iwase, Shingo Yano, Shinichiro Okamoto, Koji Oba, Junichi Sakamoto, Hisashi Sakamaki   +17 more
openalex   +2 more sources